Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial
about
Biomarkers of Renal Disease and Progression in Patients with DiabetesThe pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over timeAssociation of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health StudyLeptin and Lipid Profile in Overweight Patient with Type 1 Diabetes.Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study.The role of innate immune pathways in type 1 diabetes pathogenesis.Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus.Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Response to comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.Heritability of renal function and inflammatory markers in adult male twinsHyperketonemia (acetoacetate) upregulates NADPH oxidase 4 and elevates oxidative stress, ICAM-1, and monocyte adhesivity in endothelial cells.Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammationMultiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathyAssociation of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over timeAssociation of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes.Early nephropathy in type 1 diabetes: the importance of early renal function decline.Microinflammation in the pathogenesis of diabetic nephropathy.Diabetes and ageing-induced vascular inflammation.The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.A case of "hidden" diabetic nephropathy diagnosed by a combination of renal biopsy findings and continuous glucose monitoring system.Vascular Cell Adhesion Molecule 1, Intercellular Adhesion Molecule 1, and Cluster of Differentiation 146 Levels in Patients with Type 2 Diabetes with Complications.Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation.Low serum endothelial cell-selective adhesion molecule predicts increase in albuminuria in type 2 diabetes patients.Biomarkers in Type 2 diabetes: improving risk stratification with the PreDx ® Diabetes Risk Score.Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients
P2860
Q26799505-34042381-FC7C-4F4C-9D79-3AB0CACAB689Q28285897-0441762B-7F04-4EB5-9FB2-A51F865A8E80Q28303674-4CC0E360-6427-49BB-A2D4-9B0723632339Q33646057-7CB8B875-BBAF-4F03-80E3-9A8306BF15EBQ33984906-C696F2E1-ABA4-4EFA-B7D1-2E1E433970EFQ34002382-3BA430AB-B806-4253-877A-27EFFAACA5D3Q34066378-C43FFAFF-7C51-40DE-9604-564CD29CCABDQ34071861-87560DD8-C15B-4F96-80AB-BA12BFB7D922Q34219439-1E3399C5-1C98-4756-907D-4EDA2C12B535Q34278935-030C1E8A-4515-453A-82F1-80CAE15C136DQ34307344-B220CBD3-56F2-4AAB-91A0-2E2102C9CF92Q35022262-78D1F93B-ABBC-422E-AA11-BC6FB52ADFE1Q35070137-AD09961C-DA35-4664-BC3D-D36E8F73A2E2Q35126070-58381390-8C31-4854-98F5-DA44822A207BQ36105705-CEFA6BFE-AAFD-48C8-8C30-10443ADC013FQ36550886-B1C32A9C-C291-4F11-A99D-7185C792E53AQ36763152-68ADDCED-4854-43D4-9134-B60D01607CADQ36868327-92207136-8875-4B37-9837-7F5533EE359DQ37039772-6790DD5F-3715-4A7E-87BD-CC1A8A13166CQ37418807-B7EC2D76-3FEF-4128-A15F-AFFDA7F51988Q38213048-025F58F6-EF86-44AE-8D28-1B10BC437C94Q38598866-C2F3E30D-5A1B-45FA-8618-C266B799C6E7Q38821293-48AB2691-43F1-4B7E-A98E-8BEC8B29B9D3Q42289875-55EE34DA-C540-41ED-BA05-AF02C25A223BQ42372225-F538AAE7-3508-4A61-9BDC-368E295A807BQ43269536-0B53FB9A-E03A-4AC8-B43F-271B9457F608Q44498938-05238AD6-1C1E-47FD-8E85-A49EF2B069DDQ51366399-AA6713CD-7363-48F7-BD8C-EFD094272DA9Q54391933-BC01E7AC-AB70-41B3-BB0A-2B5EA569E8BEQ57580571-CA0C6421-480D-426B-937F-0BD7947A3A6F
P2860
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Inflammation and progressive n ...... ontrol and complications trial
@en
type
label
Inflammation and progressive n ...... ontrol and complications trial
@en
prefLabel
Inflammation and progressive n ...... ontrol and complications trial
@en
P2093
P2860
P356
P1433
P1476
Inflammation and progressive n ...... ontrol and complications trial
@en
P2093
David M Nathan
Debra A Schaumberg
JoAnn E Manson
Paul M Ridker
Robert J Glynn
P2860
P304
P356
10.2337/DC08-0277
P407
P50
P577
2008-09-16T00:00:00Z